CYTOMEGALOVIRUS PREVALENCE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS FROM A MEXICAN ONCOLOGIC REFERENCE CENTER

被引：0
|
作者：
Valero-Saldana, L. M. [1 ]
Vallejo-Cervantes, J. L. [2 ]
Aguado-Vazquez, T. [3 ]
Rivera-Fong, L. [1 ]
Cervantes-Perez, L. [1 ]
Moreira-Perez, C. [1 ]
Garzon-Velazquez, K. [1 ]
Lugo, G. [3 ]
Acosta-Maldonado, B. [1 ]
机构：
[1] Inst Nacl Cancerol, EM, Mexico City, DF, Mexico
[2] Merck Sharp & Dohme Ltd, Mexico City, DF, Mexico
[3] Merck Sharp & Dohme Ltd, Oncol, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH203
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [1] Cytomegalovirus Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Barlow, Ashley
    US PHARMACIST, 2021, 46 (04)
  • [2] Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Silva, Fernando
    Martins, Antonio
    Ferraz, Paula
    Lopes, Diogo
    Bastos, Juliana
    Araujo, Joana
    Trigo, Fernanda
    Pinto, Ricardo
    Silva-pinto, Andre
    ACTA MEDICA PORTUGUESA, 2024,
  • [3] The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
    Miriam Ciáurriz
    Amaya Zabalza
    Lorea Beloki
    Cristina Mansilla
    Estela Pérez-Valderrama
    Mercedes Lachén
    Eva Bandrés
    Eduardo Olavarría
    Natalia Ramírez
    Cellular and Molecular Life Sciences, 2015, 72 : 4049 - 4062
  • [4] The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
    Ciaurriz, Miriam
    Zabalza, Amaya
    Beloki, Lorea
    Mansilla, Cristina
    Perez-Valderrama, Estela
    Lachen, Mercedes
    Bandres, Eva
    Olavarria, Eduardo
    Ramirez, Natalia
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (21) : 4049 - 4062
  • [5] GENOTYPING OF HUMAN CYTOMEGALOVIRUS (HCMV) IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Dieamant, D. C.
    Bonon, S. H. A.
    Murakami, M. M.
    Costa, S. C. B.
    Vigorito, A. C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S277 - S278
  • [6] Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Stern, Lauren
    Withers, Barbara
    Avdic, Selmir
    Gottlieb, David
    Abendroth, Allison
    Blyth, Emily
    Slobedman, Barry
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [7] Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
    Ljungman, Per
    Hakki, Morgan
    Boeckh, Michael
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2010, 24 (02) : 319 - +
  • [8] Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
    Ljungman, Per
    Hakki, Morgan
    Boeckh, Michael
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (01) : 151 - +
  • [9] Cost Effectiveness of Letermovir as Cytomegalovirus Prophylaxis in in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Schelfhout, Jonathan
    Jiang, Yiling
    Miles, LaStella
    Merchant, Sanjay
    Graham, Jonathan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S384 - S384
  • [10] Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients
    Van Hecke, Sam
    Calcoen, Bas
    Lagrou, Katrien
    Maertens, Johan
    FUTURE MICROBIOLOGY, 2019, 14 (03) : 175 - 184
12345